Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions between taxol and camptothecin

D Debernardis1, G Cimoli, S Parodi

  • 1Department of Oncology, National Institute for Research on Cancer (IST), Genova, Italy.

Anti-Cancer Drugs
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-mount in situ detection of microRNAs on Arabidopsis tissues using Zip Nucleic Acid probes.

Analytical biochemistry·2012
Same author

Interferon-gamma enhances TNF sensitivity in A172 human glioblastoma cell line.

Oncology reports·2011
Same author

Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapy.

International journal of oncology·2011
Same author

Breast cancer and distress resulting from Magnetic Resonance Imaging (MRI): the impact of a psychological intervention of emotional and informative support.

Journal of experimental & clinical cancer research : CR·2007
Same author

Age- and gender-dependent association of the -344C/T polymorphism of CYP11B2 with blood pressure in European populations.

Journal of human hypertension·2007
Same author

Goats may experience reproductive failures and shed Coxiella burnetii at two successive parturitions after a Q fever infection.

Research in veterinary science·2006
Same journal

Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen.

Anti-cancer drugs·2026
Same journal

Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report.

Anti-cancer drugs·2026
Same journal

Growth differentiation factor-11 inhibits the progression of acute myeloid leukemia and increases chemosensitivity by inhibiting cathepsin S.

Anti-cancer drugs·2026
Same journal

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma: a case report.

Anti-cancer drugs·2026
Same journal

Drug repurposing of liver cancer based on multimodal neural network and virtual screening.

Anti-cancer drugs·2026
Same journal

Discovery of an orally active and liver-targeted dual prodrug of 5-fluoro-2'-deoxyuridine-5'-monophosphate for the treatment of hepatocellular carcinoma.

Anti-cancer drugs·2026
See all related articles

Taxol and camptothecin (CPT) are promising ovarian cancer drugs. Simultaneous administration showed Taxol inhibits CPT-induced DNA damage and cell death, suggesting they target the same nuclear enzyme, DNA topoisomerase I.

Area of Science:

  • Oncology
  • Molecular Pharmacology
  • Cell Biology

Background:

  • Taxol and camptothecin (CPT) are investigational antitumor agents.
  • Both drugs show promise in treating refractory human ovarian cancer.
  • Their individual mechanisms involve microtubule assembly (Taxol) and DNA topoisomerase I poisoning (CPT).

Purpose of the Study:

  • To investigate the molecular and cellular pharmacology of simultaneous Taxol and CPT administration.
  • To determine potential drug interactions in human ovarian cancer cells.

Main Methods:

  • Utilized human ovarian cancer cell line A2780.
  • Administered Taxol and CPT simultaneously.
  • Assessed effects on DNA single-strand breaks and cytotoxicity.

Related Experiment Videos

Main Results:

  • Taxol significantly inhibited CPT-induced single-strand DNA breaks.
  • Taxol also inhibited CPT-induced cytotoxicity.
  • These findings suggest an interaction between the drugs.

Conclusions:

  • Taxol and CPT may interact via the same nuclear enzyme, DNA topoisomerase I.
  • This interaction impacts their combined efficacy in ovarian cancer models.
  • Further research into this interaction is warranted for therapeutic development.